Variant report
Variant | nsv481709 |
---|---|
Chromosome Location | chr6:162611340-163119381 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1565)
- CpG islands (count:795)
- Chromatin interactive region (count:41)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr6:163102512-163102850 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr6:162910482-162910786 | HepG2 | liver: | n/a | n/a |
3 | ARID3A | chr6:162794306-162794665 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr6:162671087-162671724 | HepG2 | liver: | n/a | n/a |
5 | ARID3A | chr6:162857639-162857816 | HepG2 | liver: | n/a | n/a |
6 | ATF1 | chr6:163037119-163037243 | K562 | blood: | n/a | n/a |
7 | ATF1 | chr6:162782228-162782581 | K562 | blood: | n/a | n/a |
8 | ATF1 | chr6:162812215-162812339 | K562 | blood: | n/a | n/a |
9 | ATF1 | chr6:162784797-162785113 | K562 | blood: | n/a | n/a |
10 | ATF1 | chr6:162812647-162812847 | K562 | blood: | n/a | n/a |
11 | ATF2 | chr6:163042363-163042635 | GM12878 | blood: | n/a | n/a |
12 | ATF3 | chr6:163042298-163042684 | HCT-116 | colon: | n/a | n/a |
13 | ATF3 | chr6:162784742-162785052 | K562 | blood: | n/a | n/a |
14 | BACH1 | chr6:162975725-162976098 | K562 | blood: | n/a | n/a |
15 | BATF | chr6:163042398-163042636 | GM12878 | blood: | n/a | chr6:163042519-163042530 |
16 | BATF | chr6:163042347-163042655 | GM12878 | blood: | n/a | chr6:163042519-163042530 |
17 | BHLHE40 | chr6:163042376-163042676 | GM12878 | blood: | n/a | n/a |
18 | BHLHE40 | chr6:163102590-163102846 | HepG2 | liver: | n/a | n/a |
19 | BHLHE40 | chr6:162899266-162899534 | GM12878 | blood: | n/a | n/a |
20 | BRCA1 | chr6:162658617-162658742 | Hela-S3 | cervix: | n/a | n/a |
21 | BRCA1 | chr6:162871740-162871751 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | CBX3 | chr6:162784775-162785143 | K562 | blood: | n/a | n/a |
23 | CBX3 | chr6:162785538-162785848 | K562 | blood: | n/a | n/a |
24 | CCNT2 | chr6:163001825-163002025 | K562 | blood: | n/a | n/a |
25 | CEBPB | chr6:162910493-162910789 | HepG2 | liver: | n/a | n/a |
26 | CEBPB | chr6:162857234-162857635 | HepG2 | liver: | n/a | chr6:162857420-162857431 |
27 | CEBPB | chr6:162794250-162794499 | HepG2 | liver: | n/a | chr6:162794312-162794323 |
28 | CEBPB | chr6:162670249-162670473 | HepG2 | liver: | n/a | chr6:162670378-162670389 |
29 | CEBPB | chr6:163106060-163106305 | HepG2 | liver: | n/a | n/a |
30 | CEBPB | chr6:162745722-162745922 | HepG2 | liver: | n/a | chr6:162745751-162745762 |
31 | CEBPB | chr6:162871405-162871712 | H1-hESC | embryonic stem cell: | n/a | chr6:162871605-162871616 |
32 | CEBPB | chr6:163036084-163036403 | A549 | lung: | n/a | chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036235-163036248 chr6:163036235-163036248 chr6:163036237-163036246 chr6:163036116-163036129 chr6:163036236-163036247 |
33 | CEBPB | chr6:162857280-162857594 | HepG2 | liver: | n/a | chr6:162857420-162857431 |
34 | CEBPB | chr6:162861366-162861450 | H1-hESC | embryonic stem cell: | n/a | chr6:162861390-162861403 |
35 | CEBPB | chr6:162634276-162634544 | A549 | lung: | n/a | chr6:162634418-162634429 |
36 | CEBPB | chr6:162656289-162656489 | A549 | lung: | n/a | n/a |
37 | CEBPB | chr6:162672448-162672478 | HepG2 | liver: | n/a | n/a |
38 | CEBPB | chr6:163042252-163042579 | MCF-7 | breast: | n/a | n/a |
39 | CEBPB | chr6:163036070-163036411 | IMR90 | lung: | n/a | chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036235-163036248 chr6:163036235-163036248 chr6:163036237-163036246 chr6:163036116-163036129 chr6:163036236-163036247 |
40 | CEBPB | chr6:163067647-163067800 | HepG2 | liver: | n/a | chr6:163067696-163067707 |
41 | CEBPB | chr6:163036133-163036384 | Hela-S3 | cervix: | n/a | chr6:163036237-163036246 chr6:163036237-163036246 chr6:163036235-163036248 chr6:163036235-163036248 chr6:163036237-163036246 chr6:163036236-163036247 |
42 | CEBPB | chr6:162857291-162857590 | HepG2 | liver: | n/a | chr6:162857420-162857431 |
43 | CEBPB | chr6:163036076-163036363 | H1-hESC | embryonic stem cell: | n/a | chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036237-163036246 chr6:163036118-163036129 chr6:163036235-163036248 chr6:163036235-163036248 chr6:163036237-163036246 chr6:163036116-163036129 chr6:163036236-163036247 |
44 | CEBPB | chr6:162943679-162943865 | HepG2 | liver: | n/a | n/a |
45 | CEBPB | chr6:162910422-162910805 | HepG2 | liver: | n/a | n/a |
46 | CEBPB | chr6:162636016-162636253 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | CEBPB | chr6:162671584-162671889 | IMR90 | lung: | n/a | n/a |
48 | CEBPB | chr6:162779076-162779247 | A549 | lung: | n/a | chr6:162779118-162779129 |
49 | CEBPB | chr6:162839236-162839248 | A549 | lung: | n/a | n/a |
50 | CEBPB | chr6:162939387-162939585 | HepG2 | liver: | n/a | chr6:162939453-162939464 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:162684526-162684576 | GM12891 | blood: | n/a |
2 | chr6:162831837-162831887 | HRCEpiC | kidney: | n/a |
3 | chr6:162684526-162684576 | GM12891 | blood: | n/a |
4 | chr6:162831837-162831887 | HRCEpiC | kidney: | n/a |
5 | chr6:162831837-162831887 | GM12892 | blood: | n/a |
6 | chr6:162865258-162865308 | HCF | heart: | n/a |
7 | chr6:162864586-162864636 | A549 | lung: | n/a |
8 | chr6:162683857-162683907 | NH-A | brain: | n/a |
9 | chr6:163024624-163024674 | HRCEpiC | kidney: | n/a |
10 | chr6:162865258-162865308 | MCF10A-Er-Src | breast: | n/a |
11 | chr6:162683857-162683907 | K562 | blood: | n/a |
12 | chr6:162964378-162964428 | K562 | blood: | n/a |
13 | chr6:162831837-162831887 | PFSK-1 | brain: | n/a |
14 | chr6:162864586-162864636 | SK-N-SH_RA | brain: | n/a |
15 | chr6:163110854-163110904 | AG10803 | skin: | n/a |
16 | chr6:162863505-162863555 | IMR90 | lung: | fetal |
17 | chr6:162683857-162683907 | AG04449 | skin: | fetal |
18 | chr6:162831837-162831887 | SKMC | muscle: | n/a |
19 | chr6:163024624-163024674 | GM06990 | blood: | n/a |
20 | chr6:162684441-162684491 | GM12878 | blood: | n/a |
21 | chr6:162865171-162865221 | HPAEpiC | pulmonary alveolar: | n/a |
22 | chr6:162684441-162684491 | K562 | blood: | n/a |
23 | chr6:162683881-162683931 | HUVEC | blood vessel: | n/a |
24 | chr6:162684526-162684576 | K562 | blood: | n/a |
25 | chr6:162683857-162683907 | HUVEC | blood vessel: | n/a |
26 | chr6:162865171-162865221 | H1-hESC | embryonic stem cell: | embryo |
27 | chr6:162831837-162831887 | HCPEpiC | choroid plexus: | n/a |
28 | chr6:163024624-163024674 | NT2-D1 | testis: | n/a |
29 | chr6:162683961-162684011 | LNCaP | prostate: | n/a |
30 | chr6:162864586-162864636 | SK-N-SH | brain: | n/a |
31 | chr6:162684526-162684576 | SKMC | muscle: | n/a |
32 | chr6:162683881-162683931 | HIPEpiC | eye: | n/a |
33 | chr6:162683881-162683931 | SKMC | muscle: | n/a |
34 | chr6:162684526-162684576 | MCF10A-Er-Src | breast: | n/a |
35 | chr6:162863505-162863555 | SK-N-SH_RA | brain: | n/a |
36 | chr6:162865171-162865221 | HUVEC | blood vessel: | n/a |
37 | chr6:162683881-162683931 | AG04449 | skin: | fetal |
38 | chr6:163110854-163110904 | HCF | heart: | n/a |
39 | chr6:162864586-162864636 | BJ | skin: | n/a |
40 | chr6:162964378-162964428 | GM12892 | blood: | n/a |
41 | chr6:162865171-162865221 | ProgFib | skin: | n/a |
42 | chr6:162683961-162684011 | HEK293 | kidney: | embryo |
43 | chr6:162831837-162831887 | SK-N-SH_RA | brain: | n/a |
44 | chr6:162684441-162684491 | Jurkat | blood: | n/a |
45 | chr6:162684441-162684491 | HCM | heart: | n/a |
46 | chr6:163024624-163024674 | GM19239 | blood: | n/a |
47 | chr6:162864586-162864636 | HUVEC | blood vessel: | n/a |
48 | chr6:162863505-162863555 | NT2-D1 | testis: | n/a |
49 | chr6:162865258-162865308 | H1-hESC | embryonic stem cell: | embryo |
50 | chr6:162964378-162964428 | MCF10A-Er-Src | breast: | n/a |
(count:41 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:163103043..163104996-chr6:163109382..163111025,2 | K562 | blood: | |
2 | chr6:162960178..162962006-chr6:162962880..162965078,2 | K562 | blood: | |
3 | chr6:162721411..162723925-chr6:162726328..162729326,2 | K562 | blood: | |
4 | chr6:162902802..162905070-chr6:162905406..162907332,2 | K562 | blood: | |
5 | chr6:163103043..163104996-chr6:163109382..163111025,2 | K562 | blood: | |
6 | chr6:163111769..163114753-chr6:163116374..163118174,2 | K562 | blood: | |
7 | chr6:163100762..163102270-chr6:163108804..163111519,2 | K562 | blood: | |
8 | chr6:162902802..162905070-chr6:162905406..162907332,2 | K562 | blood: | |
9 | chr6:162613600..162615384-chr6:162617227..162618872,2 | K562 | blood: | |
10 | chr6:162671180..162673472-chr6:162808694..162811227,2 | K562 | blood: | |
11 | chr6:162620407..162622935-chr6:162623040..162625617,2 | K562 | blood: | |
12 | chr6:163111769..163114753-chr6:163116374..163118174,2 | K562 | blood: | |
13 | chr6:162763017..162765353-chr6:162767098..162769301,2 | K562 | blood: | |
14 | chr6:162863816..162864618-chr6:163271757..163272511,2 | MCF-7 | breast: | |
15 | chr6:163002877..163005708-chr6:163021910..163024946,3 | K562 | blood: | |
16 | chr6:162643217..162645721-chr6:162646719..162648950,2 | K562 | blood: | |
17 | chr6:162666890..162668464-chr6:162670216..162671922,2 | K562 | blood: | |
18 | chr6:163117200..163118947-chr6:163123211..163125034,2 | K562 | blood: | |
19 | chr6:163002877..163005708-chr6:163021910..163024946,3 | K562 | blood: | |
20 | chr6:162661286..162663139-chr6:162673530..162675376,2 | K562 | blood: | |
21 | chr6:162960178..162962006-chr6:162962880..162965078,2 | K562 | blood: | |
22 | chr6:162768506..162770213-chr6:162786241..162788330,2 | K562 | blood: | |
23 | chr6:162661286..162663139-chr6:162673530..162675376,2 | K562 | blood: | |
24 | chr6:162666890..162668464-chr6:162670216..162671922,2 | K562 | blood: | |
25 | chr6:162643217..162645721-chr6:162646719..162648950,2 | K562 | blood: | |
26 | chr6:163080104..163081787-chr6:163082227..163083951,2 | K562 | blood: | |
27 | chr6:162863367..162864320-chr6:163157771..163158572,4 | MCF-7 | breast: | |
28 | chr6:162799485..162803733-chr6:162804296..162807777,5 | K562 | blood: | |
29 | chr6:162799485..162803733-chr6:162804296..162807777,5 | K562 | blood: | |
30 | chr6:163100762..163102270-chr6:163108804..163111519,2 | K562 | blood: | |
31 | chr6:162820265..162823089-chr6:162827852..162829559,2 | K562 | blood: | |
32 | chr6:162721411..162723925-chr6:162726328..162729326,2 | K562 | blood: | |
33 | chr6:162613600..162615384-chr6:162617227..162618872,2 | K562 | blood: | |
34 | chr6:163077595..163080176-chr6:163085064..163087575,2 | K562 | blood: | |
35 | chr6:163077595..163080176-chr6:163085064..163087575,2 | K562 | blood: | |
36 | chr6:162768506..162770213-chr6:162786241..162788330,2 | K562 | blood: | |
37 | chr6:162820265..162823089-chr6:162827852..162829559,2 | K562 | blood: | |
38 | chr6:163080104..163081787-chr6:163082227..163083951,2 | K562 | blood: | |
39 | chr6:162671180..162673472-chr6:162808694..162811227,2 | K562 | blood: | |
40 | chr6:162763017..162765353-chr6:162767098..162769301,2 | K562 | blood: | |
41 | chr6:162620407..162622935-chr6:162623040..162625617,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRT8P44 | TF binding region |
KRT8P44 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147826497 | chr6:162611342-162611343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555532139 | chr6:162611413-162611414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115794244 | chr6:162611425-162611426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573539191 | chr6:162611429-162611430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533768736 | chr6:162611449-162611450 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529750268 | chr6:162611510-162611511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113668168 | chr6:162611520-162611521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375335066 | chr6:162611546-162611547 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566595321 | chr6:162611549-162611550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113489750 | chr6:162611555-162611556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140190325 | chr6:162611559-162611560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187486205 | chr6:162611562-162611563 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73594248 | chr6:162611569-162611570 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs537638460 | chr6:162611579-162611580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192153369 | chr6:162611591-162611592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143936446 | chr6:162611635-162611636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs115162651 | chr6:162611659-162611660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552920622 | chr6:162611719-162611720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573015543 | chr6:162611751-162611752 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184232336 | chr6:162611753-162611754 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144828403 | chr6:162611754-162611755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575835337 | chr6:162611767-162611768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367934980 | chr6:162611772-162611773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544464019 | chr6:162611809-162611810 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75215200 | chr6:162611813-162611814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs118183748 | chr6:162611817-162611818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540250343 | chr6:162611876-162611877 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560151621 | chr6:162611879-162611880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9347599 | chr6:162611892-162611893 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs117175592 | chr6:162611937-162611938 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368262207 | chr6:162611993-162611994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545400936 | chr6:162611997-162611998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs386708036 | chr6:162612002-162612003 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9355988 | chr6:162612003-162612004 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs531567486 | chr6:162612024-162612025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531013227 | chr6:162612044-162612045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9365383 | chr6:162612073-162612074 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs114312450 | chr6:162612089-162612090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549257585 | chr6:162612097-162612098 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs58841741 | chr6:162612107-162612108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7764353 | chr6:162612119-162612120 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs148520925 | chr6:162612133-162612134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538648436 | chr6:162612134-162612135 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372649620 | chr6:162612136-162612137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575629210 | chr6:162612174-162612175 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142789089 | chr6:162612175-162612176 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs151066149 | chr6:162612198-162612199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116325789 | chr6:162612202-162612203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540885646 | chr6:162612222-162612223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560761939 | chr6:162612223-162612224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Parkinson disease | 0 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Parkinson disease | 21829596 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 21346763 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Autism | 22495309 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Schizophrenia | 19805367 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:162605800-162624200 | Weak transcription | Pancreas | Pancrea |
2 | chr6:162609600-162612000 | Weak transcription | Right Atrium | heart |
3 | chr6:162609600-162622000 | Weak transcription | Left Ventricle | heart |
4 | chr6:162609600-162622400 | Weak transcription | Psoas Muscle | Psoas |
5 | chr6:162610800-162612400 | Enhancers | Fetal Heart | heart |
6 | chr6:162612000-162613000 | Enhancers | Right Atrium | heart |
7 | chr6:162612400-162615800 | Weak transcription | Fetal Heart | heart |
8 | chr6:162613000-162621600 | Weak transcription | Spleen | Spleen |
9 | chr6:162613000-162622000 | Weak transcription | Right Atrium | heart |
10 | chr6:162615800-162617200 | Enhancers | Fetal Heart | heart |
11 | chr6:162616200-162616400 | Weak transcription | Aorta | Aorta |
12 | chr6:162616200-162617200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:162617200-162621800 | Weak transcription | Fetal Heart | heart |
14 | chr6:162618800-162619200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr6:162619000-162619400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr6:162619000-162619400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr6:162619200-162622000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
18 | chr6:162619800-162620000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr6:162620600-162620800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr6:162620800-162621400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
21 | chr6:162620800-162623000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr6:162620800-162623000 | Enhancers | Adipose Nuclei | Adipose |
23 | chr6:162621000-162622800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
24 | chr6:162621200-162622200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
25 | chr6:162621600-162622000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
26 | chr6:162621600-162622400 | Enhancers | Fetal Stomach | stomach |
27 | chr6:162621800-162622200 | Enhancers | Fetal Kidney | kidney |
28 | chr6:162621800-162623000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
29 | chr6:162621800-162623000 | Enhancers | Fetal Heart | heart |
30 | chr6:162622000-162622200 | Enhancers | Right Ventricle | heart |
31 | chr6:162622000-162622400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
32 | chr6:162622000-162622400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
33 | chr6:162622000-162622400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
34 | chr6:162622000-162622400 | Enhancers | Fetal Brain Male | brain |
35 | chr6:162622000-162622400 | Enhancers | Left Ventricle | heart |
36 | chr6:162622000-162622400 | Enhancers | Rectal Smooth Muscle | rectum |
37 | chr6:162622000-162622400 | Enhancers | Right Atrium | heart |
38 | chr6:162622000-162622400 | Active TSS | Stomach Smooth Muscle | stomach |
39 | chr6:162622000-162622600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
40 | chr6:162622000-162623000 | Enhancers | Colon Smooth Muscle | Colon |
41 | chr6:162622200-162622800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
42 | chr6:162622400-162622600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
43 | chr6:162622400-162622800 | Enhancers | Psoas Muscle | Psoas |
44 | chr6:162622400-162624200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
45 | chr6:162622400-162624400 | Weak transcription | Aorta | Aorta |
46 | chr6:162622400-162624400 | Weak transcription | Fetal Stomach | stomach |
47 | chr6:162622400-162632000 | Weak transcription | Left Ventricle | heart |
48 | chr6:162622400-162636000 | Weak transcription | Right Atrium | heart |
49 | chr6:162622600-162623000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
50 | chr6:162622800-162623000 | Enhancers | Skeletal Muscle Male | skeletal muscle |